Clinical Trial Update: Pharmacokinetics of Two Formulations of Entecavir [Phase 4]

View source ↗

Summary

This clinical trial update compares the pharmacokinetics of two formulations of entecavir in patients with Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Entecavir (Baraclude) (Entecavir)

Snippet

Sponsor: Yung Shin Pharm. Ind. Co., Ltd. | Conditions: Hepatitis B | Phase 4 | Status: COMPLETED